nomifensine has been researched along with Lupus Erythematosus, Systemic in 2 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Morteo, O | 1 |
| Maldonado-Cocco, JA | 1 |
| Miescher, PA | 1 |
2 other studies available for nomifensine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Lupus-like syndrome during treatment with nomifensine.
Topics: Female; Humans; Isoquinolines; Lupus Erythematosus, Systemic; Middle Aged; Nomifensine | 1983 |
Nomifensine-induced allergic reactions.
Topics: Acute Disease; Drug Hypersensitivity; Female; Humans; Isoquinolines; Lupus Erythematosus, Systemic; | 1985 |